Medgenics, Inc. (NYSE MKT:MDGN and AIM:MEDU, MEDG) (the Company), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that Company management will participate in the Oppenheimer 24th Annual Healthcare Conference taking place from December 10-11, 2013 in New York City.
Help employers find you! Check out all the jobs and post your resume.
